Natera Inc (NAS:NTRA)
$ 124.39 0.95 (0.77%) Market Cap: 15.38 Bil Enterprise Value: 14.82 Bil PE Ratio: 0 PB Ratio: 18.35 GF Score: 72/100

Q4 2022 Natera Inc Earnings Call Transcript

Feb 28, 2023 / 09:30PM GMT
Release Date Price: $48.55 (+2.06%)
Operator

Welcome to Natera's 2022 Fourth Quarter Financial Results Conference Call. (Operator Instructions) (technical difficulty) Chief Financial Officer. Please go ahead.

Michael B. Brophy
Natera, Inc. - CFO

Thanks, operator. Good afternoon. Thank you for joining our conference call to discuss the results of our fourth quarter of 2022. On the line, I'm joined by Steve Chapman, our CEO; Solomon Moshkevich, General Manager of Oncology; and John Fesko, Chief Business Officer.

Today's conference call is being broadcast live via webcast. We will be referring to a slide presentation that has been posted to investor.natera.com. A replay of this call will also be available at investor.natera.com.

Starting on Slide 2. During the course of this conference call, we will make forward-looking statements regarding future events and our anticipated future performance, such as our operational and financial outlook and projections, our assumptions for that outlook, market size, partnerships, clinical studies, opportunities and strategies, and expectations for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot